Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Objective: An increased risk of cardiovascular morbidity and mortality in adult GH deficiency (GHD) may be related to hypopituitarism but also to the presence of the metabolic syndrome (MetS). Our objective was to investigate the characteristics and prevalence of MetS as well as its comorbidities in adult GHD. Design: In KIMS (Pfizer International Metabolic Database) 2479 patients with severe adult-onset GHD, naïve to GH replacement, with complete information on all MetS components were found. MetS was defined according to the National Cholesterol Education Program's Adult Treatment Panel III (NCEP) and the International Diabetes Foundation (IDF). Methods: The prevalence of MetS was calculated and compared with previously published data from the normal population. Associations were assessed between background variables, baseline variables, comorbidities, and MetS. Results: MetS was present in 43.1% (NCEP) and in 49.1% (IDF) of patients, clearly higher than data from the normal population (20–30%). MetS prevalence was related to age, GHD duration, and body mass index (BMI), but not to GHD severity, extent of hypopituitarism, or etiology of pituitary disease. Adjusted for age, gender, and BMI, patients with MetS had a higher prevalence ratio for diabetes mellitus: 4.65 (95% confidence interval (CI): 3.29–6.58), for cardiovascular morbidity: 1.91 (95% CI: 1.33–2.75), and for cerebrovascular morbidity: 1.77 (95% CI: 1.09–2.87) than patients without MetS. Conclusions: MetS is highly prevalent in GHD and is associated with a higher prevalence ratio for comorbidities. The presence of MetS in GHD may therefore contribute to the increased risk of cardiovascular morbidity and mortality found in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, many studies on metabolic impairments in classical hypopituitarism demonstrated that alterations are equally prevalent between isolated GHD or multiple deficits (79,91), suggesting GHD as the principal actor.”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [79]
In the citing paper
“Hypopituitarism, in general, and GHD, in particular, are associated with a number of metabolic alterations (74 -79).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [79]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
The Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009
Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide.
Fossati, P., & Prencipe, L. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.10.2077 · Cited by 2,905
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Cholesterol determination in high-density lipoproteins separated by three different methods.
Lopes-Virella, M. F., Stone, P., Ellis, S., & Colwell, J. A. (1977) · Clinical Chemistry · doi:10.1093/clinchem/23.5.882 · Cited by 1,841
Easy SAS Calculations for Risk or Prevalence Ratios and Differences
Spiegelman, D. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi188 · Cited by 1,738
Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults
Ford, E. S., Giles, W. H., & Mokdad, A. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2444 · Cited by 1,488
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2745 · Cited by 1,194
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Increased cerebrovascular mortality in patients with hypopituitarism
Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C., & Erfurth, E. M. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1749.x · Cited by 542
Prevalence and Trends of a Metabolic Syndrome Phenotype Among U.S. Adolescents, 1999–2000
Duncan, G. E., Li, S. M., & Zhou, X.-H. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2438 · Cited by 500
The effect of hypopituitarism on life expectancy.
Bates, A. S., Van't Hoff, W., Jones, P. J., & Clayton, R. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772595 · Cited by 475
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation
Simmons, R. K., Alberti, K. G. M. M., Gale, E. A. M., Colagiuri, S., Tuomilehto, J., Qiao, Q., Ramachandran, A., Tajima, N., Brajkovich Mirchov, I., Ben-Nakhi, A., et al. (2010) · Diabetologia · doi:10.1007/s00125-009-1620-4 · Cited by 456
Hildrum, B., Mykletun, A., Hole, T., Midthjell, K., & Dahl, A. A. (2007) · BMC Public Health · doi:10.1186/1471-2458-7-220 · Cited by 361
Brabant, G., von zur Mühlen, A., Wüster, C., Ranke, M. B., Kratzsch, J., Kiess, W., Ketelslegers, J.-M., Wilhelmsen, L., Hulthén, L., Saller, B., et al. (2003) · Hormone Research in Paediatrics · doi:10.1159/000071871 · Cited by 360
Self-citationSvensson, J., Bengtsson, B.-Å., Rosén, T., Odén, A., & Johannsson, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031601 · Cited by 237
Nilsson, P. M., Engström, G., & Hedblad, B. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02142.x · Cited by 207
The DECODE Study Group, & Qiao, Q. (2006) · Diabetologia · doi:10.1007/s00125-006-0438-6 · Cited by 200
Lie, R. F., Schmitz, J. M., Pierre, K. J., & Gochman, N. (1976) · Clinical Chemistry · doi:10.1093/clinchem/22.10.1627 · Cited by 161
Abs, R., Feldt-Rasmussen, U., Mattsson, A. F., Monson, J. P., Bengtsson, B.-A., Góth, M. I., Wilton, P., & Koltowska-Häggström, M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02179 · Cited by 140
Self-citationAttanasio, A. F., Mo, D., Erfurth, E. M., Tan, M., Ho, K. Y., Kleinberg, D., Zimmermann, A. G., & Chanson, P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1326 · Cited by 115
Life expectancy following surgery for pituitary tumours
Bates, A. S., Bullivant, B., Sheppard, M. C., & Stewart, P. M. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00650.x · Cited by 108
Ford, E. S., Schulze, M. B., Pischon, T., Bergmann, M. M., Joost, H.-G., & Boeing, H. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-35 · Cited by 104
Lorenzo, C., Serrano-Ríos, M., Martínez-Larrad, M. T., González-Sánchez, J. L., Seclén, S., Villena, A., Gonzalez-Villalpando, C., Williams, K., & Haffner, S. M. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-1796 · Cited by 93
van der Klaauw, A. A., Biermasz, N. R., Feskens, E. J. M., Bos, M. B., Smit, J. W. A., Roelfsema, F., Corssmit, E. P. M., Pijl, H., Romijn, J. A., & Pereira, A. M. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0699 · Cited by 86
Hillier, T., Fagot-Campagna, A., Eschwège, E., Vol, S., Cailleau, M., & Balkau, B. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyi281 · Cited by 81
Thirty Years of Bioethics: The Helsinki Declaration 1964-2003
Riis, P. (2003) · New Review of Bioethics · doi:10.1080/1740028032000131396 · Cited by 78
Cardiovascular risk factors in hypopituitary GH-deficient adults
Verhelst, J., & Abs, R. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0291 · Cited by 70
Self-citationImpact of Growth Hormone Status on Body Composition and the Skeleton
Mukherjee, A., Murray, R. D., & Shalet, S. M. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080497 · Cited by 67
Gutiérrez, L. P., Kołtowska‐Häggström, M., Jönsson, P. J., Mattsson, A. F., Svensson, D., Westberg, B., & Luger, A. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1510 · Cited by 64
Self-citationHollman, G., & Kristenson, M. (2008) · European Journal of Cardiovascular Nursing · doi:10.1016/j.ejcnurse.2007.05.003 · Cited by 61
Qiao, Q., Laatikainen, T., Zethelius, B., Stegmayr, B., Eliasson, M., Jousilahti, P., & Tuomilehto, J. (2009) · Stroke · doi:10.1161/strokeaha.108.518878 · Cited by 44
Diagnosis of adult GH deficiency
Gasco, V., Corneli, G., Rovere, S., Croce, C., Beccuti, G., Mainolfi, A., Grottoli, S., Aimaretti, G., & Ghigo, E. (2008) · Pituitary · doi:10.1007/s11102-008-0110-x · Cited by 41
Radioimmunoassay of the Somatomedins/Insulin-like Growth Factors
Underwood, L. E., & Murphy, M. G. (1987) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-71809-0_23 · Cited by 32
Klose, M., Jonsson, B., Abs, R., Popovic, V, Koltowska-Häggström, M., Saller, B., Feldt-Rasmussen, U., & Kourides, I. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0328 · Cited by 31
Self-citationSomma, C. D., Pivonello, R., Pizza, G., Rosa, A. D., Lombardi, G., Colao, A., & Savastano, S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346577 · Cited by 28
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
“● ● In ad libitum (not energy restricted) diets, intake of dietary sugars is positively linked to weight gain.(40) However,”
Influential
Metadata
- Authors
- Verhelst, J., Mattsson, A. F., Luger, A., Thunander, M., Góth, M. I., Kołtowska-Häggström, M., & Abs, R.
- Affiliations
- ZNA Middelheim Hospital (BE)
- Pfizer (Sweden) (SE)
- Medical University of Vienna (AT)
- Lund University (SE)
- Corresponding author
- Verhelst, Johan
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-12
- Volume
- 165
- Issue
- 6
- Pages
- 881-889
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2159644930
- Semantic Scholar
- af236c11504941d0430ccecc7b0c5070cf0e5703
- Cited by
- 71
- References
- 42
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 5 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 3 · 2015: 6 · 2014: 8 · 2013: 1 · 2012: 7
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- metabolic syndrome, adult-onset growth hormone deficiency, hypopituitarism, growth hormone replacement therapy, prevalence, diabetes mellitus, cardiovascular morbidity, body mass index, comorbidities
- MeSH terms
- Adult, Age Factors, Female, Humans, Hypopituitarism, Male, Middle Aged, Cohort Studies, Prevalence, Human Growth Hormone, Hormone Replacement Therapy, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.